ruxolitinib

MPL proto-oncogene, thrombopoietin receptor ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34165774 MPL overexpression induces a high level of mutant-CALR/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutations. 2021 Oct 2
2 29741513 Myelofibrosis: clinicopathologic features, prognosis, and management. 2018 Feb 1
3 25572172 JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response. 2015 Mar 1